Term 1 Pharm - Lipid Drugs Flashcards
Ultimate end goal of lipid lowering drugs
long term survival and lessen worse cardiovascular end outcomes, NOT necessarily to lower lipid levels
mechanisms of action lipid drugs:
1) Bile acid sequestrants
2) Nicotinic acid
3) Fibric acid derivatives
4) Statins
5) Inhibitors of GI absorption of cholesterol
6) New class PCSK9 inhibitors
Lipid-containing articles in blood
chylomicrons, VLDL, LDL, HDL, a
Cholesterol circulates in blood bound (mostly) to:
HDL, LDL, and TG particles
So to alter cholesterol in blood, we need to “go after” these particles
What type of cholesterol should be measured?
We used to follow total cholesterol, but now we are much more particular to measure FASTING“bad” cholesterol (LDL-chol) and “good” cholesterol (HDL-cholesterol), since they both have important clinical implications
List levels of Total cholesterol
Great: _____
Desirable: 240
List Levels of LDL
Great: 160
List Levels of HDL
Great: > 60
Desirable: > 50
Borderline: 40-50
Bad:
What type of lipid drugs alter LDL receptors?
ALL drugs (via different pathways) UPREGULATE LDL receptors
Old School Drugs:
- Cholestyramine (bile acid sequestrant)
- Nicotinic acid (vitamin)
- Gemfibrozil (fibrate)
- Ezetimibe (cholesterol absorption inhibitor)
Newer/Better drugs
Statins (HMG-CoA reductase inhibitors)
- Lovastatin (Mevacor™)
- Atorvastatin (Lipitor™)
- Rosuvastatin (Crestor™)
New class, PCSK9 inhibitors (Alirocumab, Praluent™)
Cholesterol lowering agent
Bile acid sequestrant
prevents absorption of bile salts in small bowel (gut) increasing their excretion & causing increase in bile synthesis –> increase of cholesterol synthesis –> increase of LDL receptors on surface of hepatocytes
MANY GI problems (not used often) - gas, bloating, constipation, probs with fat soluble vitamins
Lowers LDL 10-20%
Cholestyramine (Questran, colestipol)
Cholesterol lowering agent
Vitamin that is also a therapeutic agent that lowers cholesterol
Lowers BOTH TG and LDL –> causes increase of LDL receptor in liver
Absorption decreased by cholestyramine
Nicotinic Acid = Niacin Vitamin
Niacor, etc.
What is the effect of Statin + Niacin?
They do lower TG & LDL levels and increase HDL levels but they do NOT cause better clinical outcomes
But Niacin may be used in statin intolerant pts
Lipid lowering agent
Fabric acid derivative
inhibits hepatic secretion of VLDL –> lowering LDL
But MOST useful in treating hypertriglyceridemia in types IV and V hyperlipidemia (can decrease levels by 30%) an may increase HDL a little
Gemfibrozil (Lopid, fenofibrate)
Cholesterol lowering drug
primary & secondary prevention of CAD
HMG-CoA reductase inhibitor
parent drug = Lactone
causes up regulation of LDL receptors on hepatocytes causing liver to take in more cholesterol (reducing blood LDL up to 65% and increasing HDL somewhat)
Metabolized by CPT 3A4
gets transformed to an active metabolite (half life of 20-30hrs)
BE CAREFUL, watch LTFs (liver enzymes) and CPK (creatine) during first year of use –> risk of hepatitis, myopathy, etc.
Has additive effects with other lipid lowering drugs (increasing risk)
Erythromycin, cyclosporin, fluconazole, etc may inhibit CYP 3A4 metabolism causing accumulation and toxicity
AVOID in ptas with hepatitis, muscle disease and pregnant
Atorvastatin - Generic ($4)
Lipitor - Brand ($191)
Most effective/powerful 2 lipid lowering drugs
Atorvastatin($10) (brand - Lipitor)
(80mg) - 50 to 60% reduction
Rosuvastatin = Crestor (no generic yet)
(40mg) - 50 to 60% reduction
Cholesterol absorption inhibitor
Blocks intestinal absorption of cholesterol at bowel brush border & increases blood clearance of cholesterol
Usually combined with another drug/statin
Ezetimibe (Zetia)
Brand name only available $237/mo
What advantage does Rosuvastatin have over Lipitor?
It lowers CRP levels BUT overall effect of decreasing total risk is NOT proven to be greater than Lipitor
PCSK9 inhibitor
(this inhibitor usually binds to LDL receptors on hepatocytes and promotes their degradation)
This drug is a human monoclonal antibody that targets PCSK9 and increases LDL receptors in hepatocytes
Given as a SC injection every 2 weeks (half life of 12 days), cleared by proteolysis
CAN cause hypersensitivity reaction (or reaction at injection site)
Little data on long term efficacy & safety
Given to patients who don’t respond to statins
Praluent = Aliroc’umab
$1,120/mo!!